Several studies have supported current recommendations of seasonal influenza vaccination in COPD patients as it causes exacerbations and indicated its positive risk -benefit ratio. Moreover, International and National health organizations also stated the use of seasonal influenza vaccine even though its coverage remains sub-optimal as compared to the recommended target.
In the light of above, is influenza vaccination effective in preventing adverse clinical outcomes or deaths in patients with COPD?
